Latest California Healthline Stories
Government-Funded Scientists Laid the Groundwork for Billion-Dollar Vaccines
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.
Can Ordinary COVID Patients Get the Trump Treatment? It’s OK to Ask
If you or a loved one has COVID-19, here’s what to consider before seeking experimental treatments.
¿Pueden los pacientes de COVID tener el tratamiento de Trump? Está bien preguntar
Muchos pacientes desconocen estas opciones o simplemente no pueden, o no saben, cómo acceder a ellas. Otros desconfían de los tratamientos no probados.
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
KHN’s ‘What the Health?’: The Politics of Science
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
Dozens of U.S. Hospitals Poised to Defy FDA’s Directive on COVID Plasma
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they’ll opt instead to use the scarce resource to complete a clinical trial.
Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming
The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
Fauci dice que una vacuna contra COVID podría estar lista antes de lo esperado
El experto en enfermedades infecciosas de más alto rango en el país dice que esto podría ocurrir si los ensayos clínicos en curso producen resultados abrumadoramente positivos.
Turning Anger Into Action: Minority Students Analyze COVID Data on Racial Disparities
About 70 college students are enrolled this summer in a program developed by San Francisco researchers and funded by the National Institutes of Health that allows them to explore the pandemic’s impact on communities facing health disparities.
Estudiantes de minorías analizan datos de COVID sobre disparidades raciales
Los datos para abordar las brechas raciales en la atención en las comunidades más necesitadas, y sus resultados, han sido escasos durante la pandemia.